Table 2.
The KEGG top 10 pathway related information.
| Term | Count | P Value | Genes |
|---|---|---|---|
| Pathways in cancer | 19 | 2.15E-08 | EGLN1, HSP90AA1, ROCK1, MMP2, STAT3, PRKCA, FGF1, PTGS2, FGF2, EGFR, IL2, VEGFA, CASP7, EDNRA, CASP8, CASP3, AKT2, AKT1, MET |
| Alzheimer disease | 12 | 8.83E-05 | BACE1, APP, CASP7, CASP8, AKT2, CASP3, PSEN2, NOX4, AKT1, PSEN1, PTGS2, TNF |
| PI3K-Akt signaling pathway | 12 | 2.16E-04 | HSP90AA1, AKT2, KDR, AKT1, PRKCA, FGF1, FGF2, MET, EGFR, IL2, VEGFA, CASP3 |
| Lipid and atherosclerosis | 11 | 2.97E-06 | CASP7, HSP90AA1, CASP8, CASP6, AKT2, CASP3, STAT3, CASP1, AKT1, PRKCA, TNF |
| Human cytomegalovirus infection | 11 | 4.47E-06 | CASP8, ROCK1, AKT2, CASP3, STAT3, AKT1, PRKCA, PTGS2, TNF, EGFR, VEGFA |
| MAPK signaling pathway | 10 | 4.61E-05 | AKT2, CASP3, KDR, AKT1, PRKCA, FGF1, TNF, FGF2, MET, EGFR |
| cGMP-PKG signaling pathway | 10 | 2.93E-06 | EDNRA, ROCK1, AKT2, ADORA1, AKT1, PDE5A, ADRA2C, ADRA1A, ADRA2B, ADRA2A |
| cAMP signaling pathway | 10 | 2.84E-05 | HTR6, EDNRA, ROCK1, AKT2, PDE4D, ADORA1, HTR1B, AKT1, DRD1, DRD2 |
| Pathways of neurodegeneration-multiple diseases | 10 | 7.24E-03 | APP, CASP7, CASP8, CASP3, PSEN2, NOX4, PRKCA, PSEN1, PTGS2, TNF |
| EGFR tyrosine kinase inhibitor resistance | 9 | 8.80E-08 | AKT2, STAT3, KDR, AKT1, PRKCA, FGF2, MET, EGFR, VEGFA |